Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials. [electronic resource]
Producer: 20170623Description: 1521-9 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Analysis of Variance
- Angiogenesis Inhibitors -- therapeutic use
- Choroidal Neovascularization -- drug therapy
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Prospective Studies
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retina -- pathology
- Tomography, Optical Coherence
- Visual Acuity -- drug effects
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.